Business Wire | November 02, 2023
Absolute Software™, the leading provider of self-healing, intelligent security solutions, today announced the launch of Absolute Application Health. This new feature empowers digital enterprises to strengthen cyber resilience and boost end user productivity with the industry’s most resilient application health monitoring capabilities. With this latest innovation to the company’s Secure Endpoint product line, customers can monitor the health of more than 2,000 commonly used Windows and Mac applications – including security controls, business, and productivity tools – to ensure they are installed, running, and properly configured on all devices.
“Organizations deploy millions of endpoint devices to support growing remote workforces around the world, and they invest billions of dollars into security controls needed to protect their networks against advanced threats and costly compliance violations,” said Sarah Pavlak, Industry Principal, Frost & Sullivan. “Despite all these efforts and money spent, organizations continue to experience increasing attacks and complexity challenges that severely disrupt business operations. This is leading to a continual need for innovations that can mitigate software failures and close security gaps.”
Absolute’s 2023 Resilience Index reveals that on average, enterprise endpoint devices have 67 applications deployed, with 10 percent of these having more than 100 applications installed. In analyzing 10 of the most widely deployed security tools, the report also shows seven of those 10 apps were installed and healthy on less than 80 percent of deployed devices, on average. In some cases, apps were only functioning correctly 47 percent of the time.
said John Herrema, Chief Product Officer, Absolute Software.
Today’s digital enterprises are investing billions of dollars in mission-critical security and business tools, and we believe those applications should deliver their intended value. The complexity and fragility of endpoint applications, however, means that all too often they are failing. And if the tool you use to monitor your other applications is subject to those same failures, then you’re really in trouble, because it’s impossible to fix what you can’t reliably see or diagnose. This latest innovation builds on Absolute’s unique Persistence technology to provide the industry’s most resilient visibility and monitoring capabilities. This allows our customers to achieve maximum security, productivity, and return on their software investments.
With Absolute Application Health, IT and security practitioners gain the deep visibility needed to ensure applications are installed, running, up-to-date, and properly configured across their entire device fleet. They also have access to detailed, interactive reports and widgets that enable them to swiftly diagnose why an application is failing and then take remedial action.
Embedded in the firmware of more than 600 million devices, Absolute’s patented Persistence® technology provides a secure, always-on connection between the Absolute Platform and the endpoint. The new Application Health feature leverages this digital tether to ensure health monitoring and reporting remains uninterrupted.
Absolute Application Health is available now to Absolute Secure Endpoint customers subscribed to eligible Absolute Resilience licenses. For more information, including how to access and activate this new feature, visit our latest blog.
About Absolute Software
Absolute Software makes security work. We empower mission-critical performance with advanced cyber resilience. Embedded in more than 600 million devices, our cyber resilience platform delivers endpoint-to-network access security coverage, ensures automated security compliance, and enables operational continuity. Nearly 21,000 global customers trust Absolute to protect enterprise assets, fortify security and business applications, and provide a frictionless, always-on user experience.
PR Newswire | November 03, 2023
DuPont announced that DuPont™ Liveo™ Healthcare Solutions is collaborating with STMicroelectronics a global leader in semiconductor technology serving customers across the spectrum of electronics applications, to develop a new smart wearable device concept for remote biosignal-monitoring.
"Dedicated Liveo™ research teams collaborate with suppliers and manufacturers worldwide to create solutions across a vast array of medical applications – including smart devices that can share data between patients and doctors," said DuPont™ Liveo™ Global Business Leader Eugenio Toccalino. "The wearable device concept that resulted from the collaboration between DuPont and ST is the DuPont™ Liveo™ Smart Biosensing Patch prototype, which employs multifunctional microsensors and control electronics from ST embedded in a flexible patch design from DuPont."
By collaborating with others across the healthcare ecosystem – from technology developers and material suppliers to device fabricators and OEMs – DuPont is developing more patient-centric solutions that contribute to better patient outcomes.
Simone Ferri, STMicroelectronics AMS Group Vice-President and MEMS sub-group General Manager.
ST designed the electronics and sensors for the smart skin patch prototype using our accelerometer and vertical analog front end next-generation sensors with in-sensor AI, a microcontroller with Bluetooth module, ultra-low-power-management units, firmware, and algorithm support to create a flexible board design capable to analyze electrical and mechanical heart activity in full synchronization to extract multiple vital signs. The performance of ST's electronic sensors is enhanced by the conformability and conductivity of the DuPont™ Liveo™ materials used to create the patch.
[Source: PR Newswire]
Through this collaboration, DuPont brings a broad range of medical patch technologies, including DuPont™ Liveo™ Soft Skin Conductive Tape 1-3150 – a silicone-based thermoset adhesive for sensing and transferring electrical biosignals, and Liveo™ Soft Skin Adhesives.
ST's sensor and embedded development technology and semiconductor manufacturing expertise, combined with the key benefits of silicone technology with electrically conductive properties allow Liveo™ Soft Skin Conductive Tape technology to be used as a skin electrode for biosignal-monitoring applications where good skin conformability, no drying over time, and repositionability with gentle adhesion and atraumatic removal is vital. It can be used in single electrodes for short-term monitoring, as well as in medical wearable patches for long-term monitoring lasting seven or more days.
DuPont also designed the layout for the Liveo™ Smart Biosensing Patch and supplied rapid prototyping capabilities.
The result of this collaboration is not just a single prototype, but a robust ST-empowered Liveo™ Smart Biosensing Patch technology toolbox for remote ECG and SCG monitoring.
The DuPont and ST integrated patch technology is designed to improve people's lives, making it easier to use than typical rigid box designs. It's smaller, lighter, and more comfortable and can be worn longer. Plus, the sensors are multifunctional, intelligent, and adaptable, and the data provided is extremely stable.
DuPont will demonstrate the capabilities of the Liveo™ Smart Biosensing Patch prototype at the MEDICA Trade Fair in Dusseldorf, Germany, November 13-16. The Liveo™ team will be in Hall 12/D33 in the Wearable Technologies Pavilion.
As part of the MEDICA Connected Healthcare Forum, DuPont™ Liveo™ Healthcare Solutions Global Strategic Marketing Manager Jennifer Gemo and ST's Head of EMEA Healthcare and Well-Being Vertical Strategic Business Development Oriana Di Marco will present "Towards intelligent e-skin patches for cardiac monitoring" featuring the DuPont/ST collaborative patch concept and technology toolbox. The presentation will take place on Nov. 14 from 12:15 to 12:35 p.m. CEST in Hall 12/E37.
DuPont offers a broad portfolio of high-performance, medical-grade elastomers, adhesives, resins and thermoplastics designed to meet the rigorous requirements of wearable medical devices. The company also provides support in the areas of materials research, application development, technology, safety and regulatory compliance.
Whether for drug delivery or smart monitoring devices, DuPont™ Liveo™ Healthcare Solutions helps enable positive patient outcomes through increasingly advanced medical technology.
PR Newswire | October 26, 2023
Walgreens and Hartford HealthCare will add health clinics to select Walgreens locations in Connecticut, advancing a unique retail health model based on convenience, access to care, affordability and health equity. This is Walgreens first retail clinic collaboration with a health system in New England.
Under a clinical collaboration agreement, five clinics operated by Hartford HealthCare medical providers will be added to Walgreens locations, including 340 Flanders Road, in East Lyme (at Flanders Four Corners); 2 Shaker Road, in Enfield; 235 Main Street, in Norwalk; and 203 Kennedy Drive, in Putnam. One additional location will be announced in the coming months. Hartford HealthCare at Walgreens clinics are scheduled to open within a year and will offer primary care, screenings, vaccinations, confidential telehealth services and more, seven days per week by appointment or walk-in.
The collaboration is based on the organizations' shared vision to improve access to care, reduce healthcare costs and offer convenient access to essential primary care and pharmacy services. The locations will offer consumers a convenient destination to access both Walgreens experience in community retail health and pharmacy operations and Hartford HealthCare's expertise in delivering patient care, employing highly qualified medical professionals, and operating health centers.
Hartford HealthCare at Walgreens will combine in-person care from a medical professional and, when needed, confidential in-store virtual care. For ease of access, an employee of Hartford HealthCare Medical Group will provide patient registration and point-of-care services, while a Medical Group primary care provider will offer private virtual care visits, including referrals as needed. Rounding out the experience, patients will have convenient access to Walgreens pharmacy and retail services.
said Jeffrey A. Flaks, President and Chief Executive Officer of Hartford HealthCare
Hartford HealthCare is intent on changing the way healthcare is delivered, and this collaboration with Walgreens is another example of the variety of convenient offerings and care settings we are adding. Our organizations are working together to combine resources and best practices to create an innovative retail health environment that meets consumers' needs and exceeds their expectations.
"Walgreens is committed to providing patients the care they need when and how it is most convenient for them," said John Driscoll, executive vice president and president, U.S. Healthcare, Walgreens Boots Alliance. "Through this special collaboration with Hartford HealthCare, we can help keep patients more connected to high-quality care and foster long-term relationships and behaviors that help patients get and stay healthy."
Together, Walgreens and Hartford HealthCare will provide one-stop convenience — a community health destination offering a health clinic, pharmacy services and retail all in one location. Patients can see their provider, pick up their medications and go shopping at their neighborhood Wcapitalalgreens. Nearly 80% of Americans live within five miles of a Walgreens store.